Search results
-
Mr Oscar Baldwin
... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...
-
Dr Saif Ahmad
I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...
-
Dr Sujath Abbas
... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...
-
Professor Walid Khaled
... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...
-
Dr David Gilligan
David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...
-
Mr David Thurtle
Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer
-
Dr Roisin Owens
Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...
-
Mr Thierry Lefebvre
Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...
-
Miss Ariella Stewart
-
Miss Anita Balakrishnan
-
Dr Alejandra Bruna
We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...
-
Professor Antonis Antoniou
My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...
-
Dr Aideen Daly
-
Miss Alicia Gonzalez Diaz
-
Mr Arman Ghodsinia
-
Professor Andrew Flewitt
I work in large area electronics and MEMS devices, with a particular focus on acoustic wave devices using thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic pumps without...
-
Professor Alan Warren
Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...
-
Dr Alan Barnicle
-
Mr Angelos Kolias
Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...
-
Miss Ee June Chua
-
Dr Jose Anselmo Coelho Lima Junior
-
Dr Kate Fife
Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...
-
Professor Kathryn Lilley
The research carried out in the Cambridge Centre for Proteomics centres around three main areas: ? Development of quantitative proteomics techniques for use in conjunction with membrane proteins, organelle proteomics and protein trafficking and applying...
-
Dr Liew Jun Mun
-
Dr Michael Gattens
I have been a consultant in paediatric haematology in Addenbrooke's since 2004. I am responsible for the care of children with malignant and non-malignant haematological conditions, accepting referrals from the East of England region. I am principal...
-
Dr Namshik Han
I am a computational drug discovery scientist, coming from a background in machine learning, computational biology, cancer genomics and cancer epigenomics. I am Head of Computational Research & AI at Milner Therapeutics Institute in University of...
-
Dr Tim Mitchell
Sareum is a drug discovery and development company delivering targeted small molecule therapeutics, primarily focusing on cancer. ...
-
Dr Annalisa Mupo
... a molecularly diverse malignancy representing 15-20% of all childhood and around 35% of all adult leukemias. My work aims to study commonly ...
-
Dr Amos Burke
Dr Amos Burke is a childhood cancer specialist working at Addenbrooke's providing a service for ... in the East of England. He has a particular interest in childhood lymphomas and is a member of the National Cancer Research Institute ...
-
Dr Anny Wong
Dr Anny Wong is a childhood cancer specialist working at Addenbrooke's. Her role includes ...
-
Professor Matthew Murray
... microRNAs (miR-), in malignant germ cell tumours and other childhood cancers. Our lab has a particular interest in circulating microRNA ...
-
Dr Simon Richardson
... rate and B-ALL remains one of the leading causes of death in childhood. Furthermore, survival rates from adult B-ALL remain poor. Using a ...
-
Dr Ali Amin Al Olama
... has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the ...
-
Dr Andreas Bender
... large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I ...
-
Dr Catherine Lindon
... to coordinated cell division, and have well documented cancer-promoting activities. Ongoing projects in the lab explore how ... in time and space, and how their activity contributes to cancer. We have recently described a 'ubiquitome' of cellular components ...
-
Dr Alison Dunning
Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput ... (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely ... consortia for breast, ovarian, endometrial and prostate cancer association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA ...
-
Dr Ashray Gunjur
... broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David ... between gut microbiota and outcomes in patients with rare cancer types. ...
-
Dr Ahsan MEMON
... this holographic system was deployed to the study of cancer and stem cell shape regulation and the role of effective membrane ...
-
Dr Aisling Redmond
... She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), ...
-
Dr Alasdair Russell
... for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a ...
-
Dr Anna Piskorz
... with potential application in clinic like shallow whole genome sequencing for copy number alterations detection, alternative tumour ...
-
Professor Anthony Davenport
... ?orphan? GPCRS, originally predicted to exist from the human genome but recently paired with their cognate transmitters (urotensin II, ...
-
Dr Alex Cagan
... Our group works with laser capture microdissection and genome sequencing to describe and understand these processes of somatic ...
-
Dr Claudia Ribeiro de Almeida
... antibody responses against pathogens, while maintaining genome stability and cellular homeostasis. ...
-
Dr Catherine Green
... We are investigating the mechanisms and control of genome replication, both at genetic and epigenetic levels. It is during ...
-
Dr David Adams
David performs forward genetic screens to uncover cancer genes and pathways and leads a programme to decode the genomes of several mouse strains. He also leads the Mouse Genomes Project and the Mouse Genetics Project. The Mouse Genomes Project is...
-
Dr Daniel Barnes
... and prostate cancer in men. I am particularly interested in genome-wide association analyses, fine-mapping, polygenic risk score, ...
